MARKET

INBXV

Inhibrx Inc
INBXV
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-
852.21
131.28
-
INHIBRX BIOSCIENCES INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH NEW COMPANY
Reuters · 04/01 20:05
INHIBRX BIOSCIENCES INC QTRLY SHR LOSS $3.09
Reuters · 03/17 20:05
INHIBRX BIOSCIENCES ANNOUNCES PRELIMINARY DATA FROM THE PHASE 1 TRIAL OF OZEKIBART (INBRX-109) FOR THE TREATMENT OF COLORECTAL CANCER
Reuters · 01/21 22:01
INHIBRX BIOSCIENCES INC - PHASE 1 TRIAL SHOWS 1 COMPLETE RESPONSE, 3 PARTIAL RESPONSES, 6 STABLE DISEASE CASES
Reuters · 01/21 22:01
INHIBRX BIOSCIENCES INC - ENTERS $150 MILLION LOAN AGREEMENT WITH OXFORD FINANCE
Reuters · 01/13 21:15
INHIBRX Q3 OPERATING EXPENSES USD 46.797 MILLION
Reuters · 11/14/2024 21:24
INHIBRX BIOSCIENCES INC: LEGAL VICTORY IN A TRADE SECRETS CASE BROUGHT BY I-MAB BIOPHARMA
Reuters · 11/04/2024 21:00
INHIBRX BIOSCIENCES INC <INBX.O>: JEFFERIES RAISES TARGET PRICE TO $15 FROM $11
Reuters · 10/02/2024 03:19
More

Webull offers Inhibrx Inc stock information, including NASDAQ: INBXV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INBXV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INBXV stock methods without spending real money on the virtual paper trading platform.